Hints and tips:
...Hempton, known for his bets against companies such as Valeant Pharmaceuticals and Wirecard, raised concerns about the level of insurance extended to Greensill by IAG, calling it “potentially a solvency risk...
...Five years later, the group bought CP Pharmaceuticals in Wrexham....
...And John Hempton of Bronte Capital, known for his bets against companies such as Valeant Pharmaceuticals and Wirecard, said he raised concerns about Greensill with Australia’s financial regulator in November...
...After a 40 per cent gain in 2014, Mr Ackman suffered a run of bad bets, mostly notably on pharmaceutical group Valeant and a bet against nutritional supplement seller Herbalife, which led to four consecutive...
...“We will have to do the same export paperwork for Northern Ireland as we do for the Philippines — that doesn’t seem right,” she added....
...This long-acting, injectable regimen is being co-developed as part of a collaboration with Janssen Sciences Ireland UC, and is not currently approved by regulatory authorities anywhere in the world, the...
...In the past few weeks, a group of 130 shareholders, including some founding family members, has sought to derail Takeda Pharmaceutical’s planned £46bn acquisition of Ireland’s Shire....
...Last year, Takeda acquired US oncology group Ariad Pharmaceuticals for $5.2bn and it later tried to acquire Valeant, the Canadian drugmaker, for around $10bn. but the talks collapsed over price....
...In June Carlyle teamed up with Pacific Equity Partners, an Australian buyout group, to buy iNova Pharmaceuticals from Valeant Pharmaceuticals in a deal worth US$930m....
...The first to crumble was Valeant Pharmaceuticals, a vehicle for buying smaller drugmakers and jacking up treatment prices backed by hedgie Bill Ackman....
...Mr Ackman subsequently took a large stake in Valeant that he exited at a big loss earlier this year, saying it had been “a huge mistake”....
...Under her leadership, the company transformed itself from a ragbag of intellectual property rights into a healthcare group that operates in interventional medicine, pharmaceuticals and licensing....
...However, Capita has been awarded contracts from the BBC and Northern Ireland authorities in the past three months....
...The company bought cancer specialist Dendreon from Valeant Pharmaceuticals in 2017 for about $820m....
...Pershing Square has been bloodied by billions of losses at Valeant Pharmaceuticals and struggled to make a return at the burrito chain Chipotle....
...Shares in Valeant, the embattled drugmaker, rallied on Thursday after it disclosed the sale of its iNova Pharmaceuticals business to private equity funds managed by Pacific Equity Partners and Carlyle Group...
...Corporate earnings reports out today include Aberdeen Asset Management, GW Pharmaceuticals, Avanza Bank, Moscow Exchange and Neopost....
...ValueAct has previously agitated for management changes at Rolls-Royce, and driven merger and acquisition activity at groups as diverse as Valeant Pharmaceuticals and insurance broker Willis Towers Watson...
...Facebook to stop booking ad sales through Irish HQ After a long love affair with Ireland, Facebook became one of the first major technology companies to decide to book less of its revenues in the low-tax...
...When Bill Ackman sold what remained of his disastrous investment in Valeant Pharmaceuticals earlier this month, he said it was because it was taking up too much of his time and too much of his conversations...
...Canadian drugmaker Valeant Pharmaceuticals International Inc said Tuesday it will sell controversial prostate-cancer drug maker Dendron Pharmaceuticals to Chinese conglomerate Sanpower Group Co – which also...
...The news came hours after Takeda Pharmaceuticals, which late last year came close to paying Valeant $10bn for one of its units, ran off with Ariad Pharmaceuticals for $5bn....
...The Valeant stake was sold in March this year, at a more than 90 per cent loss, after the emergence of regulatory and accounting concerns at Valeant....
...from Canadian drugmaker Valeant for $10bn in November....
International Edition